Charles River Laboratories | Lånekapital

Loan Capital Endring Dato
Agilent USD 2.56B 180M 2023-12
Bio-Rad Laboratories USD 1.2B 339K 2023-12
Bruker USD 1.16B 61.7M 2023-12
Cardinal Health USD 3.54B 355M 2023-12
Catalent USD 4.96B 637M 2023-12
Charles River Laboratories USD 2.65B 132.93M 2023-12
Cigna USD 28.09B 21M 2023-09
CVS Health USD 58.64B 1.14B 2023-12
Dentsply International USD 1.8B 7M 2023-12
Galapagos EUR 8.47M 736K 2023-09
Hologic USD 2.54B 9.1M 2023-12
Illumina USD 1.49B 0 2023-12
Incyte USD 29.16M 303K 2023-12
IQVIA Holdings USD 12.96B 633M 2023-12
Laboratory Of America USD 4.13B 374.5M 2023-12
Lonza CHF 2.46B 907M 2023-06
McKesson USD 5.54B 76M 2023-09
Merck EUR 9.54B 45M 2023-09
Mettler Toledo International USD 1.89B 40.78M 2023-12
Pfizer USD 61.05B 308M 2023-09
Revvity USD 3.18B 25.32M 2023-12
United Therapeutics USD 300M 200M 2023-12
Walgreens Boots Alliance USD 8.49B 571M 2023-09
Waters USD 2.46B 124.93M 2023-09
West Pharmaceutical Services USD 206.8M 54.7M 2023-12



Charles River Laboratories Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.